Objectives: To analyse and compare mcr-1-bearing plasmids from animal Escherichia coli isolates, and to investigate potential mechanisms underlying dissemination of mcr-1.
Introduction
The continuous emergence of novel antibiotic resistance-encoding genetic elements among the major bacterial pathogens in recent years has undermined current efforts to devise new antimicrobial strategies, and poses an enormous threat to public health. 1, 2 Polymyxins, including polymyxin B and colistin, are cationic antimicrobial peptides which act on Gram-negative bacteria by disrupting the outer and inner membranes. 3, 4 Polymyxins were discovered in the late 1940s but deemed unsuitable for treatment of bacterial infections because of their neurotoxic effects; however, emergence of MDR Gram-negative bacteria has prompted a renewed interest in this old antibiotic, which is currently regarded as a possible last-resort agent to eradicate MDR organisms. 5, 6 Resistance to colistin has been reported among different bacterial species, the underlying mechanism of which is mainly intrinsic in nature. On the other hand, acquired resistance due to modifications of the bacterial outer membrane, efflux pumps and capsular polysaccharides have also been reported. 3, 7 Recently, pioneering work performed by Liu et al. 8 described the recovery of a conjugative plasmid-mediated polymyxin resistance gene mcr-1, which encodes an enzyme belonging to the phosphoethanolamine transferase enzyme family, from both animals and human. 8 Following this discovery, a number of studies have reported the presence of mcr-1 in different species of Enterobacteriaceae which exhibited MDR phenotypes recovered from farmed animals, food samples and clinical settings around the world. 9, 10 The emergence of mcr-1 has been traced back to Escherichia coli strains isolated in the 1980s when colistin was first introduced into veterinary practice in China, 11 indicating that this gene has existed in food animals for a considerable period.
Plasmids harbouring mcr-1 have been reported to include the IncX4, IncI2, IncP, IncFII and IncHI2 types. 9,12 -15 The prevalence of mcr-1 in plasmids harboured by different bacterial species highlights its potential of being transferred horizontally. Notably, mcr-1 was often found to be located downstream of ISApl1, 13 which is an IS belonging to the IS30 family. 16 The close genetic association between ISApl1 and mcr-1 indicates that ISApl1 may play a pivotal role in the dissemination of mcr-1. Data regarding the complete sequences of mcr-1-bearing plasmids and the role of ISApl1 in mediating transposition of the mcr-1 gene are scarce. In this study, we aimed to investigate if the mcr-1 gene was prevalent in farm settings, and the range of plasmids which harboured such a resistance gene. By characterizing the mcr-1-bearing plasmids in E. coli isolated from farmed animals in different parts of China, we discovered a mcr-1-bearing transposable element which can form a circular intermediate that plays a key role in genetic translocation, and hence transmission of the mcr-1 element among a wide range of potential human pathogens.
Materials and methods

Bacterial strains and identification
Cefotaxime-resistant E. coli strains were isolated from faeces of healthy pigs on six farms located in six provinces in China, namely Guangdong, Fujian, Jiangsu, Shandong, Henan and Liaoning, during the period September 2014 -March 2015, by using MacConkey agar plates supplemented with 4 mg/L cefotaxime. The strains were identified as E. coli by MALDI-TOF MS using a Bruker MicroFlex LT mass spectrometer (Bruker Daltonics) and confirmed using API20E strips (bioMérieux, Inc.).
Antimicrobial susceptibility tests
MICs of 14 antimicrobial agents as listed in Table S1 (available as Supplementary data at JAC Online) were determined using the agar dilution method; results were interpreted according to CLSI recommendations. E. coli strain ATCC 25922 was used as a quality control strain.
Prevalence of mcr-1-positive E. coli strains All E. coli strains were screened for the presence of the mcr-1 gene by PCR using primers as previously described. 8 The PCR products were purified and sequenced by Sanger sequencing to confirm the genetic identity.
XbaI-PFGE, S1-PFGE and Southern hybridization E. coli strains that carried the mcr-1 gene were subjected to further characterization. PFGE of XbaI-digested genomic fragments was performed to assess the genetic relatedness of isolates, using the CHEF-MAP-PER System (Bio-Rad); genomic DNA of the Salmonella enterica var. Braenderup H9812 strain restricted with XbaI was used as the reference standard. Cluster analysis of PFGE patterns was typically performed by the BioNumerics (Applied Maths) system. S1 nuclease-PFGE was performed to characterize the plasmid profiles; the location of mcr-1 was identified by Southern hybridization with digoxigenin-labelled mcr-1 probe according to the manufacturer's instructions for the DIG-High Prime DNA Labeling and Detection Starter Kit II (Roche Diagnostics).
Plasmid sequencing and bioinformatics analyses
Plasmids extracted from the 15 bacterial strains using the QIAGEN Plasmid Midi Kit were used to prepare the sequencing libraries, which were constructed by the NEBNext w Ultra TM II DNA Library Prep Kit for Illumina w (NEB) and sequenced by the NextSeq 500 Illumina platform, with 2×150 bp paired-end reads. De novo assembly of the reads was conducted with SOAPdenovo2, 17 followed by the use of ResFinder 17 and PlasmidFinder 18 to identify resistance genes and plasmid types among the scaffolds. Construction of complete plasmid sequences was accomplished by using available plasmid reference sequences to align and assemble the contigs, and confirmed by mapping paired-end reads to the finished complete sequences. In an attempt to obtain the complete gene map of mcr-1-bearing plasmids that in silico analysis failed to produce, PacBio RSII single-molecule, real-time (SMRT) sequencing was performed to create libraries of 20 kb at the Wuhan Institute of Biotechnology, Wuhan, China. The library preparation work was conducted according to the instructions of the manufacturer, Pacific Biosciences. Illumina contigs were joined together by using the PacBio long contigs after assembly with HGAP 3.0. The annotations of the plasmid sequences were conducted by RAST 19 and edited manually. Alignments with highly homologous complete plasmid sequences available in NCBI for these three plasmid types were performed by using the BRIG tool. 20 Comparison of four complete mcr-1 IncHI2 plasmids was performed and visualized with Easyfig. 21 The representative mcr-1-bearing plasmid sequences pECJS-59-244, pECJS-B60-267, pECJS-61-63 and pECGD-8-33 were submitted to NCBI with the accession numbers KX084394, KX254341, KX254342 and KX254343, respectively.
Detection of circular intermediates
Based on the knowledge that the IS30 family ISs could form DNA circular intermediates 22 and that ISApl1 exhibits similarity with the IS30 family members (39% identity with IS30 transposase from E. coli NP_414790 in protein sequence), a set of reverse primers targeting mcr-1 was designed to investigate the potential of the ISApl1-mcr-1 segment to circularize (Table S2 ). The PCR products were sequenced by Sanger sequencing to obtain a complete map of the circular intermediate.
Results
Characterization of mcr-1-positive, ESBL-producing E. coli Among the 97 cefotaxime-resistant E. coli strains isolated from faecal samples of pigs from various farms, 35 isolates (36%) were found to harbour the mcr-1 gene. These mcr-1-positive strains, which were isolated from pigs in farms located in five geographically diverse provinces of China, were shown to exhibit genetically divergent PFGE types ( Figure S1 ). However, strains collected from the same province were generally genetically more related than those obtained from other provinces (data not shown). The MICs of colistin were either 4 or 8 mg/L for all the mcr-1-positive strains, with the majority exhibiting resistance to multiple antimicrobial agents except meropenem (Table S1) . To obtain a comprehensive view of the genetic features of mcr-1-bearing plasmids in these isolates, 15 mcr-1-positive E. coli strains of different PFGE types were selected for further characterization. S1-PFGE and Southern hybridization analysis showed that each of these isolates carried multiple plasmids, among which some were found to harbour more than one mcr-1-bearing Li et al.
plasmid. The size of plasmids observed in these isolates ranged from 33 to 280 kb, with three major categories being observable: 33, 60 and 216-280 kb. Most of the strains were found to harbour one 33 or 60 kb plasmid, with some, such as strains FJ-B42 and JS-B65, carrying both. Some strains, such as JS-B60, JS-64, JS-B73 and JS-59, were also found to carry one mcr-1-bearing plasmid of 216 -280 kb in size (Table 1) .
Genetic characterization of plasmids harbouring the mcr-1 gene
Plasmids extracted from the 15 mcr-1-positive strains were subjected to nucleotide sequencing using the Illumina platform. Raw reads were subjected to de novo assembly to obtain contigs for each sample. BLASTN analysis against the resistance gene database, using the Illumina contigs, showed that plasmids recovered from these 15 strains comprised multiple drug resistance determinants (Table S3) ; this finding was consistent with the MDR phenotypes observable among the test strains (Table S2 ). In addition to mcr-1, plasmids derived from most of the strains were found to harbour multiple resistance elements, including but not limited to bla CTX-M , bla CMY , bla TEM , fosA, qnrS, floR and oqxAB. However, it should be noted that there is still a slight possibility that some of the resistance genes (Table S3) were not plasmid borne, and were presumably located in the chromosome since the plasmid DNA used for high-throughput sequencing could be contaminated by chromosomal DNA, a phenomenon confirmed by other sequencing projects in our laboratory.
Six IncX4, seven IncI2 and seven IncHI2 plasmids were confirmed to harbour the mcr-1 gene among the 15 test strains, five of which were found to contain two mcr-1-bearing plasmids (Table 1) . The complete plasmid sequences of 33 and 60 kb plasmids could be obtained by in silico analysis of the Illumina sequencing data using the corresponding reference sequences (pHNSHP45 and pECJS-B65-33). The 33 kb plasmid, pECGD-8-33, obtained from sample GD-8, was shown to belong to the IncX4 type, comprising 55 coding sequences (CDSs) with a size of 33 307 bp, and an overall GC content of 41.84%. The complete plasmid sequence of the 60 kb plasmid, pECJS-61-63, obtained from sample JS-61, was shown to belong to the IncI2 type and comprise 88 CDSs, with a size of 63 656 bp and a GC content of 42.64%. The complete plasmid sequences of the 216-280 kb plasmids could not be generated from the Illumina sequencing data. Two representative plasmids, from samples JS-59 and JS-B60, respectively, were subjected to PacBio sequencing to obtain the complete sequence. The complete sequence of a 216-280 kb category plasmid, namely pECJS-59-244, which was derived from sample JS-59, was obtained. It was shown that this plasmid belonged to the IncHI2 type, contained 321 CDSs, and had a size of 243 572 bp, of which the GC content was 46.10%. Another IncHI2 plasmid, pECJS-B60-267, which was obtained from sample JS-B60, was found to be 267486 bp in size. These two IncHI2-type plasmids were compared with the contigs of IncHI2 plasmids in other samples (Figure 1 ). IncHI2-type plasmids have been reported as genetic elements mediating the transmission of MDR genes (Table S4) . Results of comparative analysis showed that a wide range of resistance genes and genetic elements could be found in a mosaic MDR region of IncHI2-type plasmids, including integrons, ISs and various resistance gene cassettes. The map of mcr-1-bearing plasmids could be completed successfully by using references of similar types to assist assembly of contigs of different samples, with the exception of IncHI2-type plasmids, The size of the plasmids was determined according to the S1-PFGE results.
b Plasmids for which complete sequences have been obtained. Complete sequences were not available in five IncHI2 mcr-1-bearing plasmids, for which only the assembly scaffolds were generated. The replicon types of samples were confirmed by PCR using specific primers listed in Table S2 . c The mcr-1 locus for pECFJ-44-250 and pECJS-63-230 was unavailable.
Characterization of mcr-1-bearing plasmids JAC which contained a large MDR region with numerous ISs. As a result, complete sequences of six IncX4-type, seven IncI2-type and two IncHI2-type plasmids were obtained using this approach (Table 1) .
Plasmids belonging to each of these three types obtained from this study, and genetically similar mcr-1-bearing plasmids reported previously, were subjected to comparative analysis. Figure S2 . Information about the IncHI2 plasmids tested in this study is provided in Table 1 . This figure is available in colour in the online version of JAC and in black and white in the print version of JAC.
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The 33 kb, IncX4-type plasmids harboured by E. coli strains isolated from different geographical locations of China as well as other countries were found to be almost identical (Figure 2) . Apart from mcr-1, no other resistance genes were detectable; in addition, no ISApl1 elements were found to flank the mcr-1 gene.
A genetically homologous, yet mcr-1-negative plasmid of this type, namely pSH146_32, was previously isolated from a Salmonella Heidelberg strain (JX258655), suggesting that the mcr-1-orf gene cassette was most likely introduced into this plasmid backbone to form a mcr-1-bearing plasmid of this type (Figure 2) . Figure 2 . Sequence alignment of IncX4-type mcr-1-bearing plasmids. pESTMCR, which was recovered in Estonia with GenBank no. KU743383, was used as reference to match with other IncX4-type plasmids with (six plasmids in this study and pmcr1_IncX4, KU761327) and without the mcr-1 gene (pSH146_32, JX258655). The outer circle with red arrows denotes the annotation of reference sequence. pSH146_32 exhibits a lower degree of sequence homology to the reference sequence when compared with other plasmids, and is depicted by a grey circle instead of the light pink colour chosen to represent this plasmid. The figure shows that the six IncX4 plasmids tested in this study and two previously reported IncX4 plasmids (pESTMCR and pmcr1_IncX4) share an extremely high degree of sequence homology. Information about the IncX4 plasmids tested in this study is provided in Table 1 . This figure is available in colour in the online version of JAC and in black and white in the print version of JAC.
Characterization of mcr-1-bearing plasmids
JAC
The 60 kb, IncI2-type mcr-1 plasmid was present in 7 out of the 15 samples. Compared with pHNSHP45, which was first reported to encode the MCR-1 protein, 23 an IS683 region was found to be missing in all seven IncI2-type plasmids isolated in this study (Figure 3) . Two of the plasmids were found to contain an ISApl1-mcr-1 cassette identical to that of pHNSHP45, whereas another five plasmids lacked the ISApl1 gene. The 216 -280 kb, IncHI2-type plasmids, which harboured a large MDR region, was the most genetically diverse plasmid type (Figure 1, Figure S2 ). Unlike the IncX4-and IncI2-type plasmids, for which the structure and location of the mcr-1 cassettes were consistent among members of each plasmid type, the insertion site of the mcr-1 cassette Figure 3 . Sequence alignment of seven IncI2-type mcr-1-bearing plasmids. pHNSHP45 with GenBank no. KP347127 was used as a reference to compare with other mcr-1-bearing plasmids which possess the IncI2 replicon. The outer circle with red arrows signifies annotation of the reference sequence. Gaps in the circle refer to plasmid regions which are missing when compared with the reference. The IS683 element is absent in all of the seven IncI2 plasmids tested in this study (see Table 1 for details). IncI2 plasmids can be categorized into two subtypes based on the presence or absence of ISApl1. This figure is available in colour in the online version of JAC and in black and white in the print version of JAC.
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in IncHI2 plasmids was variable and could be categorized into four types, which differed by the truncation status of orf, and the orientation and numbers of ISApl1 elements (Figure 4 , Figure S2 ). Alignment of mcr-1-bearing elements revealed the core structure of all known mcr-1 cassettes detectable in this and previous studies. Our data showed that the most conserved structure was the mcr-1-orf structure (the orf encodes the putative PAP family transmembrane protein). However, three of the six structures were found to have lost this intact orf due to alteration of the last four nucleotides in this element (Figure 4 ). Furthermore, a newly deposited mcr-1-bearing IncHI2 plasmid named pSA26-MCR-1 (KU743384), which was recovered from an NDM-1-producing E. coli ST68 strain isolated from a blood sample from a Saudi Arabian patient, was found to harbour a new mcr-1 cassette in which the second copy of ISApl1 is inserted into the orf region in a reverse manner, indicating that the putative PAP orf is not required for evolution of mcr-1 cassettes. Another 20 non-mcr-1 IncHI2 plasmids exhibiting homology to pECJS-B60-267 (coverage .70%, identity .98% by BLASTN in the NCBI database) were extracted and the resistance gene distribution was examined ( Figure S3 , Table S4 ). The number of resistance genes in these 24 IncHI2 plasmids (including the four mcr-1-bearing plasmids) ranged from 2 to 17, and carbapenemase-encoding genes, such as bla IMP-8 , bla KPC-3 and bla VIM-1 , were found in five plasmids. Since the insertion site of mcr-1 in IncHI2 may vary, according to the four complete IncHI2 plasmids ( Figure S2 ), we hypothesize that these four plasmids acquired the mcr-1 gene by different genetic evolutionary routes.
Formation of a circular intermediate containing the mcr-1 gene cassette
Reverse primers targeting the mcr-1 gene were used to amplify the putative circular intermediate that harboured the mcr-1 gene. PCR products with a size of 2.5 kb in length were amplified in four samples harbouring the IncHI2 mcr-1 plasmids (Figure 5b ).
Sequence analysis showed that the 2.5 kb PCR products were composed of partial sequences at both the 5 ′ and 3 ′ ends of the mcr-1 gene, one orf, and one copy of ISApl1. When combined with the central region of the mcr-1 gene (the sequence between MCR1-R and MCR1-RC-F), we concluded that the circular intermediate was 3679 bp in size, containing one copy of ISApl1, mcr-1 and one orf (Figure 5a ). After aligning with the pECJS-59-244 sequence, we found that this circular form was 100% homologous to position 173391-177069 (KX084394), suggesting that the ISApl1 element in the circular intermediate was derived from the downstream ISApl1 element, which differed from the upstream ISApl1 by one nucleotide at the potential promoter region (upstream ISApl1: CTTCCAA-ISApl1, downstream ISApl1: TTTCCAA-ISApl1). Notably, the circular intermediate can only be generated when the mcr-1-orf was surrounded by direct repeats of ISApl1. The four plasmid samples from which the circular intermediate could be amplified were found to contain an mcr-1 gene cassette flanked by two intact ISApl1 elements. This new composite transposon was designated Tn6330 (ISApl1-mcr-1-orf-ISApl1), in which two directly oriented copies of ISApl1 flank the mcr-1 gene and therefore exhibit the potential to form a circular intermediate ( Figure 5 ).
Discussion
Since the discovery of the mcr-1 element in China in late 2015, 8 the mobile colistin resistance determinant has been reported among different Enterobacteriaceae species isolated from various sources in different countries. 9, 10, 23 However, there is a lack of information regarding the genetic context of plasmids harbouring this gene and the underlying transmission mechanisms. In this study, we surveyed the prevalence of the mcr-1 gene in ESBL-producing E. coli strains isolated from different geographical locations in China and conducted a comprehensive analysis of the plasmids that harboured the mcr-1 gene in 15 representative strains. Three major types of plasmids, namely IncX4 ( 33 kb), Another plasmid with a new format mcr-1 gene cassette, namely pSA26-MCR-1, is described in Figure S2 . IncI2-type plasmids can be divided into two subtypes based on the presence or absence of ISApl1. All the IncX4-type plasmids are identical in terms of genetic arrangement in the vicinity of the mcr-1 gene. This figure is available in colour in the online version of JAC and in black and white in the print version of JAC.
Characterization of mcr-1-bearing plasmids JAC IncI2 ( 60 kb) and IncHI2 ( 216 -280 kb), were detectable, alone or in various combinations, in as few as 15 E. coli strains, suggesting that mcr-1 can be captured by a wide range of mobile genetic elements circulating among bacterial strains of animal origin. Among such plasmids, we noted that the IncX4 type ( 33 kb) was genetically the least variable, whereas the IncHI2 type ( 216 -280 kb) was the most divergent due to the fact that this type of plasmid contains an MDR region which comprises a variable combination of antibiotic resistance genes ( Figure S3 ). Plasmids of similar backbone but lacking the mcr-1 gene cassette, such as pHXY0908 and pHK0683, have previously been reported in Salmonella spp., suggesting that the formation of this IncHI2 type of plasmid is most likely due to the acquisition of the mcr-1 gene cassette by vectors containing such backbone structure. 24 In this work, four types of genetic cassettes harbouring the mcr-1 gene have been identified in the IncHI2-type plasmids, suggesting that the mcr-1 gene may be actively inserted into different genetic loci of the plasmid during dynamic gene transposition events that commonly occur in animal isolates. Although only four complete mcr-1-bearing IncHI2 plasmids are available, the different locations of mcr-1 in these plasmids, and the fact that MDR IncHI2 plasmids are prevalent among human pathogens, infer that IncHI2 is the most efficient vehicle for disseminating mcr-1 and other resistance elements including the carbapenemase-encoding genes. The clinical significance of this category of plasmid is therefore highlighted by its potential to confer, in a wide range of pathogens, phenotypic resistance to carbapenems and colistin, both last-line antibiotics used to treat Gram-negative bacterial infections. The existence of plasmid pSH146_32, which belongs to the IncX4 type ( 33 kb) in Salmonella Heidelberg (JX258655), supported the notion that acquisition of the mcr-1 gene cassette by specific prototype plasmids plays an important role in the transmission of the colistin resistance element. Although no prototype plasmid of IncI2 ( 60 kb) has been reported previously, two mcr-1 gene cassettes observable in Salmonella enterica and E. coli strains in England and Wales could be found through bioinformatics analysis, 12 suggesting that insertion of the mcr-1 gene cassette into this type of plasmid is also a common event, and such plasmid has spread worldwide.
It is known that some members of the IS family, including IS3, IS30, IS110, IS26 and ISCR1, utilize circular DNA intermediates that contain accessory genes to undergo gene translocation, through copy-and-paste or cut-and-paste mechanisms. 25 -28 ISApl1 is a type of IS surrounded by a pair of left and right inverted repeats (IRL and IRR), which was first identified in Actinobacillus pleuropneumoniae, with the ability to disrupt a range of genes in such species. 16 The fact that the mcr-1 gene is consistently associated with ISApl1 and that the mcr-1 gene cassette may be inserted into different genetic loci in different plasmids, prompted us to hypothesize that mcr-1 translocation could be mediated through a circular intermediate with the aid of ISApl1. 13, 29 In this study, we provide direct evidence that all mcr-1 gene cassettes containing ISApl1-mcr-1-orf-ISApl1, designated as Tn6330, can form a circular intermediate which mediates the insertion of the mcr-1 gene cassette into the IncHI2 plasmid backbone, and possibly other plasmids. In the first study on ISApl1, a circular form harbouring only ISApl1 was detected without other accessory genes. 16 This is in agreement with the fact that no circular form containing mcr-1 can be detected when only one copy of ISApl1 is located upstream of mcr-1, or in cases where such an element does not exist. With the help of ISApl1, the generation of a circular intermediate undoubtedly confers on mcr-1 the ability to be translocated into different genetic sites in the plasmid. We also note that the number of ISApl1 around mcr-1 in the IncX4 (0), IncI2 (1 or 0) and IncHI2 (1 or 2) plasmids varies. Notably, another complete mcr-1-bearing IncHI2 plasmid, pSA26-MCR-1, was found to harbour three copies of ISApl1 ( Figure S2) , with the mcr-1 gene being flanked by two ISApl1 elements in the form of inverted repeats, possibly constituting another transposable element format. This observation, together with the fact that the degree of genetic similarity within IncX4-and IncI2-type plasmids is high but IncHI2-type plasmids are genetically divergent, may suggest that Tn6330 insertion into the IncHI2 type is still highly active, yet the loss of ISApl1 in the mcr-1 gene cassette in the IncX4-and IncI2-type plasmids renders these plasmids more stable, since the mcr-1 gene cassette in these vectors is no longer transposable. Nevertheless, the molecular mechanisms underlying the formation of the circular intermediate of Tn6330, and how it Li et al.
evolves to become a genetically stable fragment in the residing plasmid, require further investigation.
In conclusion, this study characterized in detail the diverse genetic features of mcr-1-bearing plasmids in E. coli isolated from food animals, and revealed the presence of a novel transposon Tn6330 comprising an mcr-1 gene cassette with the structure ISApl1-mcr-1-orf-ISApl1, which may be regarded as the key element responsible for mediating the translocation of the mcr-1 gene cassette into various plasmid backbones through formation of a circular intermediate. The findings in this work therefore provide important insights into the transmission mechanisms of mcr-1, and lay the foundation for devising effective intervention approaches aimed at preserving the value of colistin as a last-line antimicrobial agent.
